New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic

New Biotechnology publication validates Crescendo Biologics’ platform as it moves towards the clinic

View PDF

Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

Crescendo Biologics to collaborate with world-leading oncology groups at the University of Oxford and the University of Surrey

View PDF

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

Crescendo Biologics strengthens leadership team with appointment of ex-GSK Stewart Kay, as Chief Business Officer

View PDF 

Crescendo Biologics to present preclinical data on its lead Humabody® candidate, CB307, at the Cell Engager Therapeutics Summit 2019

Crescendo Biologics to present preclinical data on its lead Humabody® candidate, CB307, at the Cell Engager Therapeutics Summit 2019

View PDF